Comorbidity of Airway Inflammatory Diseases in Chemical and Building-Related Intolerance.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29227362.
- Also identified by DOI 10.1097/JOM.0000000000001249.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study investigated comorbidity in chemical intolerance (CI) and building- related intolerance (BRI) with (i) chronic sinusitis, chronic obstructive pulmonary disease, allergic and nonallergic asthma and allergic rhinitis, and (ii) airway inflammatory symptoms. Data from two population-based questionnaire surveys, the Västerbotten and Österbotten Environmental Health Studies, were used. The participants were categorized as CI or BRI and referents, and binary logistic regression analysis was applied. Prevalence rates for the case groups were 7.2% to 40.0% for diseases and 24.3% to 68.9% for symptoms, whereas adjusted odds ratios (ORs) were 3.4 to 26.1 for diseases and 3.3 to 17.0 for symptoms, all being significantly higher than unity. Prevalence rates and ORs were in general higher in BRI than in CI. Inflammatory airway diseases and symptoms are associated with CI and BRI, which encourages further research regarding underlying mechanisms and treatments.
Medical subject headings
- Asthma
- Multiple Chemical Sensitivity
- Pulmonary Disease, Chronic Obstructive
- Rhinitis, Allergic
- Sick Building Syndrome
- Sinusitis